StonvexLoading…
StonvexStonvexStonvexCore line items from WRBY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $242.56M | $242.45M | $871.90M | $659.94M | $438.26M |
Operating Income | Not available | $1.67M | $-5.34M | $1.52M | $-2.05M |
Net Income | Not available | $3.18M | $1.64M | $7.59M | $-1.75M |
EPS (Diluted) | $0.12 | $0.03 | $0.01 | $0.06 | $0.01 |
Total Assets | Not available | $736.41M | $720.92M | $706.92M | $701.90M |
Total Liabilities | Not available | $360.60M | $353.19M | $337.30M | $340.45M |
Cash & Equivalents | Not available | $288.25M | $286.36M | $280.36M | $286.38M |
Free Cash Flow OCF − CapEx | Not available | $8.37M | $43.74M | $35.60M | $37.12M |
Shares Outstanding | Not available | 125.55M | 125.10M | 124.89M | 125.72M |